The Future Health Dialogue, Abu Dhabi
November 3, 2026Digistain nominated for the EIT Awards 2026
November 3, 2026In September 2026 Sasha Becejac, Digistain’s CCO, was invited to speak at On Targeted Molecular Oncology 2026 in Ankara, Türkiye, sharing the latest developments around Digistain Breast with pathologists, surgeons and oncologists.
